Skip to Main Content
Brown University
The Warren Alpert Medical School

Pathology and Laboratory Medicine

Secondary Navigation Navigation

  • Give Now
Search Menu

Site Navigation

  • Home
  • About
    • Affiliated Hospitals
    • Community
    • News
  • People
    • Faculty
    • Residents
    • Fellows
    • Leadership and Administration
  • Education
    • Residency and Fellowship
    • MD Education
    • MD/PhD
    • Graduate Study
    • Postdoctoral Training
    • Undergraduate Education
    • Medical Technology Education
  • Research
    • Core Facilities
    • Research Areas
    • Research Centers, Institutes, and Facilities
    • Research Training
  • Contact Us
Search
Pathology and Laboratory Medicine

News Archive

  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
Date September 1, 2020
All News
Share
Facebook Twitter_X Linkedin Email

Highlighted Faculty Publication

Immunotherapy fails in a significant proportion of cancer patients. But a new study in Cell Death Discovery suggests that blocking the tumor-promoting protein MDM2 could bolster the treatment’s effectiveness.

Defensive Maneuver

Sahin, I., Zhang, S., Navaraj, A., Zhou, L., Dizon, D., Safran, H., & El-Deiry, W. S. (2020). AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing. Cell Death Discovery, 6(1), 57. doi:10.1038/s41420-020-0292-1

Immunotherapy fails in a significant proportion of cancer patients. But a new study in Cell Death Discovery suggests that blocking the tumor-promoting protein MDM2 could bolster the treatment’s effectiveness.

“Immunotherapy has been one of the biggest breakthroughs in biomedical science and medicine of the last two decades,” says Wafik S. El-Deiry, MD, PhD, a professor of pathology and laboratory medicine and associate dean for oncologic sciences. “But it has limitations.”

Some people’s tumors respond to immunotherapy initially and then relapse. Other patients experience pseudoprogression, where tumors appear to grow before eventually shrinking. And a third group—between 5 percent and 29 percent of patients—experience hyperprogression: immunotherapy actually worsens their tumor growth.

El-Deiry hopes that blocking MDM2, either through gene silencing or the MDM2-inhibiting drug AMG-232, could help people with hyperprogression.

Various studies have found that when cells contain too many copies of the MDM2 gene, or when the MDM2 protein is overexpressed because the gene isn’t being regulated properly, tumor cells tend to grow more quickly and are more resistant to immunotherapy. MDM2 is also associated with higher levels of the tumor-promoting inflammatory protein interleukin-6 (IL-6).

In their study, El-Deiry and his colleagues treated cell lines of MDM2-overexpressing ovarian cancer cells with AMG-232. Their data show the drug allowed immune cells to kill the tumor cells much more efficiently, and reduced levels of IL-6. This suggests that MDM2 inhibitors combined with immunotherapy could enhance its effectiveness, and El-Deiry hopes this will lead to a clinical trial.

The study was published shortly after the launch of the Cancer Center at Brown, which brings together 150 investigators from across the University and affiliated hospitals who are studying basic biology and disease epidemiology, understanding risk factors, and developing therapies.

The center focuses on cancers with higher rates in Rhode Island, as well as issues of access and affordability. El-Deiry, the center’s inaugural director, wants the center to achieve a National Cancer Institute-Cancer Center Support Grant.

“We are working methodically, in a focused way, toward that,” he says, “collaborating for the benefit of patients.”

Brown University
Providence RI 02912 401-863-1000

Quick Navigation

  • Division of Biology and Medicine
  • Program in Biology
  • Affiliated Hospitals

Footer Navigation

  • Events
  • Maps and Directions
  • Contact Us
  • Accessibility
Give To Brown

© Brown University

The Warren Alpert Medical School
For You
Search Menu

Mobile Site Navigation

    Mobile Site Navigation

    • Home
    • About
      • Affiliated Hospitals
      • Community
      • News
    • People
      • Faculty
      • Residents
      • Fellows
      • Leadership and Administration
    • Education
      • Residency and Fellowship
      • MD Education
      • MD/PhD
      • Graduate Study
      • Postdoctoral Training
      • Undergraduate Education
      • Medical Technology Education
    • Research
      • Core Facilities
      • Research Areas
      • Research Centers, Institutes, and Facilities
      • Research Training
    • Contact Us

Mobile Secondary Navigation Navigation

  • Give Now
People
Advanced Search
Close Search

Highlighted Faculty Publication